Bearish flow noted in Teva (TEVA) with 8,983 puts trading, or 3x expected. Most active are Dec-24 16 puts and Dec-24 15.5 puts, with total volume in those strikes near
Bearish flow noted in Teva (TEVA) with 8,983 puts trading, or 3x expected. Most active are Dec-24 16 puts and Dec-24 15.5 puts, with total volume in those strikes near
Teva Pharmaceutical ( ($TEVA) ) has provided an update. Teva Pharmaceutical Industries has appointed Chen Lichtenstein as a new independent Board member, effective December 1, 2024. With a robust background
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed
לאחר פגישה עם הנהלת Teva, UBS בטוחים בתחזית החיובית שלהם לחברה, ושומרים על מחיר יעד גבוה של 26$, שהוא מעל הממוצע בוול סטריט. למרות שערכה של Teva ירד ב-1.3 מיליארד
UBS walked away from meetings with Teva (TEVA) management confident that the firm’s bullish thesis with a Street-high price target of $26 is intact. The shares have lost $1.3B of